TP53BP1 and neoplasm: We focused on 53BP1, as the DNA end-binding protein 53BP1 is a well-known antagonist of DNA end resection and, thereby, of compensatory, error-prone DSB repair pathways in HR-defective tumor cells such as BRCA1-mutated TNBC [219,220].